409316-82-1 Usage
Functional groups
Hydroquinone derivative, Bromo substituent, Methyl substituents
Structure
A benzene ring with two hydroxyl (-OH) groups at the 1,4-positions, a bromine atom at the 2-position, and two methyl groups at the 3,5-positions
Appearance
Not specified in the material, but likely a solid due to its molecular structure
Physical properties
Not specified in the material, but may include melting point, boiling point, density, and solubility in various solvents
Chemical properties
Reactivity with other compounds due to the presence of bromine and methyl groups, potential for use as a building block in organic synthesis
Uses
Not widely documented, but potentially useful in the synthesis of other organic compounds, and as a building block for specialized or niche applications in organic chemistry
Applications
Potentially in the fields of photography, cosmetics, and pharmaceuticals, due to its hydroquinone derivative nature
Further study
Interesting compound for further research and potential industrial applications due to its bromine and methyl groups
Safety and handling
Not specified in the material, but should be handled with care due to its chemical reactivity and potential hazards associated with bromine-containing compounds
Check Digit Verification of cas no
The CAS Registry Mumber 409316-82-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,9,3,1 and 6 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 409316-82:
(8*4)+(7*0)+(6*9)+(5*3)+(4*1)+(3*6)+(2*8)+(1*2)=141
141 % 10 = 1
So 409316-82-1 is a valid CAS Registry Number.
409316-82-1Relevant articles and documents
Reductive and Bioreductive Activation is Controlled by Electronic Properties of Substituents in Conformationally-Constrained Anticancer Drug Delivery Systems
Weerapreeyakul, Natthida,Visser, Petra,Brummelhuis, Mathijn,Gharat, Laxmikant,Chikhale, Prashant J.
, p. 148 - 163 (2007/10/03)
Conformationally-constrained, anticancer drug delivery systems (TDDS) containing the methyl ester of melphalan (as a model drug) were synthesized using electron-withdrawing or electron-donating functional groups to modulate reductive and bioreductive activation. The electronic nature of substituents in TDDS was found to control reductive and bioreductive activation of TDDS, thus influencing drug delivery from TDDS.
